The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 6 , Pages 1447-1451 , June 2010

A follow-up of integrated positron emission tomography/computed tomography after curative resection of non–small-cell lung cancer in asymptomatic patients

  • Sukki Cho, MD

      Affiliations

    • Corresponding Author InformationAddress for reprints: Sukki Cho, MD, Department of Thoracic and Cardiovascular Surgery, Kyungpook National University Hospital, 200 Dongduk-Ro, Jung-gu, Daegu, 700-721, Korea.
    • ,
  • Eung Bae Lee, MD, PhD

Received 19 April 2009 ,Revised 16 September 2009 ,Accepted 29 September 2009.

References 

  1. Clifton F, Mountain MD. Revisions in the international system for staging lung cancer. Chest. 1997;111:1711–1717
  2. Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps CD, et al. Survival after recurrent non small-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007;83:409–418
  3. Virgo KS, McKirgan LW, Caputo MCA, Mahurin DM, Chao LC, Caputo NA, et al. Post-treatment management option for patients with lung cancer. Ann Surg. 1995;222:700–710
  4. Walsh GL, O'Connor M, Willias KM, Milas M, Wong RS, Nesbitt JC, et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective?. Ann Thorac Surg. 1995;60:1563–1572
  5. Edelman MJ, Meyers FJ, Siegel D. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med. 1997;12:318–331
  6. Younes RN, Gross JL, Deheinzelin D. Follow-up in lung cancer. How often and for what purpose?. Chest. 1999;115:1494–1499
  7. Westeel V, Choma D, Clement F. Relevance of an intensive postoperative follow-up after surgery for non–small lung cancer. Ann Thorac Surg. 2000;70:1185–1190
  8. Rubins J, Unger M, Colicce GL. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest. 2007;132:355–367
  9. National Comprehensive Cancer Network. Practice guidelines for non–small cell lung cancer. Rockledge (PA): National Comprehensive Cancer Network; 2000;
  10. Bruzzi JF, Munden RF. PET/CT imaging of lung cancer. J Thorac Imaging. 2006;21:123–136
  11. Hicks RJ, Kalff V, MacManus MP, Ware RE, McKenzie AF, Matthews JP, et al. The utility of F-FDG PET for suspected recurrent non–small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification. J Nucl Med. 2001;42:1605–1613
  12. Keidar Z, Haim N, Guranlnik L, Wollner M, Bar-Shalom R, Ben-Nun A, et al. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med. 2004;45:1640–1646
  13. Inoue T, Kim EE, Komaki R, Wong FC, Bassa P, Wong WH, et al. Detecting recurrent or residual lung cancer with FDG–PET. J Nucl Med. 1995;36:788–793
  14. Benamore R, Shepherd FA, Leighl N, Pintilie M, Patel M, Feld R, et al. Does intensive follow-up alter outcome in patients with advanced lung cancer?. J Thorac Oncol. 2007;2:273–281
  15. American Society of Clinical Oncology treatment of unresectable non–small cell lung cancer guideline: update 2003. J Clin Oncol. 2004;22:330–353
  16. Follow-up of non–small cell lung cancer: American College of Radiology appropriateness criteria, 2005.
  17. Lee HY, Chung JK, Jeong JM, Lee DS, Kim DG, Jung HW, et al. Comparison of FDG–PET findings of brain metastasis from non–small cell lung cancer and small-cell lung cancer. Ann Nucl Med. 2008;22:281–286

 Disclosures: None.

PII: S0022-5223(09)01323-3

doi: 10.1016/j.jtcvs.2009.09.055

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 6 , Pages 1447-1451 , June 2010

Article Tools

* Image Usage & Resolution